These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8999430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and some reactions of 2-acetylimidazo[4,5-b]pyridine. Antituberculotic activity of the obtained compounds.
    Bukowski L, Janowiec M, Zwolska-Kwiek Z, Andrzejczyk Z.
    Pharmazie; 1999 Sep; 54(9):651-4. PubMed ID: 10522269
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis of imidazo [4,5-b] pyridine-7-carboxylic acid and some of its derivatives with expected antituberculous activity.
    Bukowski L.
    Pol J Pharmacol Pharm; 1980 Sep; 32(5):767-72. PubMed ID: 6791143
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and some reactions of 1-methyl-1H-2-cyanomethyl-imidazo[4,5-b]pyridine. Tuberculostatic activity of obtained compounds.
    Bukowski L, Janowiec M.
    Pharmazie; 1990 Dec; 45(12):904-7. PubMed ID: 2129248
    [Abstract] [Full Text] [Related]

  • 7. Some reactions of 2-cyanomethyl-3-methyl-3H-imidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
    Bukowski L.
    Pharmazie; 2001 Jan; 56(1):23-7. PubMed ID: 11210662
    [Abstract] [Full Text] [Related]

  • 8. New imidazo [4,5-b]pyridine carboxylic acids and their derivatives with expected tuberculostatic activity.
    Bukowski L, Janowiec M.
    Pharmazie; 1988 May; 43(5):315-7. PubMed ID: 3140255
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC, Oliver AG, Markley LD, Cho S, Franzblau SG, Miller MJ.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3493-8. PubMed ID: 24909079
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L, Sridevi JP, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2016 Jul 01; 26(13):3135-3140. PubMed ID: 27184765
    [Abstract] [Full Text] [Related]

  • 14. [Synthesis and tuberculostatic activity of various 2-mercapto- and 2-oxoimidazo (4,5-c)pyridine derivatives].
    Czarnocka-Janowicz A, Janowiec M, Stambrowska A.
    Acta Pol Pharm; 1983 Jul 01; 40(1):21-31. PubMed ID: 6410690
    [No Abstract] [Full Text] [Related]

  • 15. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR, Nilsson MT, Gising J, Lagerlund O, Muthas D, Nordqvist A, Karlén A, Larhed M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4790-3. PubMed ID: 19560924
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.
    Barot KP, Jain SV, Gupta N, Kremer L, Singh S, Takale VB, Joshi K, Ghate MD.
    Eur J Med Chem; 2014 Aug 18; 83():245-55. PubMed ID: 24972340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.